This page contains exclusive content for the member of the following sections: TTS, CTS, IPITA, ISODP, IXA, ITA, TID, IHCTAS, IPTA. Log in to view.
Presenter: David Assis, Julie Heimbach, New Haven, CT, USA
Authors: David Assis, Julie Heimbach, Sukru Emre
Treatment of autoimmune liver diseases have many challenges both pre and post transplantation including decision making for transplantation, specific transplant evaluation process, transplant surgery and postoperative care. In this webinar, these problems will be discussed by 2 expert in this field.
David Assis Biography:
Dr. David N. Assis is a hepatologist and assistant professor of medicine at Yale University School of Medicine. His training in liver diseases, including research fellowship and transplant hepatology, took place at Yale. He now focuses on autoimmune liver diseases in his clinical practice and also performs NIH-funded translational research to better understand the mechanisms of Autoimmune Hepatitis, Primary Biliary Cholangitis and Primary Sclerosing Cholangitis, and to develop new immune-based therapies for treatment of these disorders.
Julie K. Heimbach Biography:
Julie K. Heimbach, M.D., is a Professor of Surgery and the Chair of the Division of Transplantation Surgery at Mayo Clinic in Rochester, Minnesota. She is currently a member of the Governing Board of the American Association for the Study of Liver Disease; chair of the Communications Committee of the American Society of Transplant Surgeons; and chair of the Liver and Intestinal Transplant Committee of the OPTN/UNOS, the national organization charged with oversight of organ transplantation in the United States. She also serves as associate editor of the American Journal of Transplantation. Dr. Heimbach’s research focuses on living donor transplantation, obesity and transplantation, and liver transplantation for hilar cholangiocarcinoma.
By viewing the material on this site you understand and accept that: